SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Supergen (supg)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Russian Bear who wrote (45)2/2/1999 8:27:00 PM
From: BRAVEHEART  Read Replies (1) of 124
 
Hi Russian Bear,

I followed Sparta closely. Excellent model to advance products. Poorly managed from a shareholder's perspective. I didn't buy SPTA until after the reverse. I targeted it as a buy at .40 only based on technicals. Clearly the product pipeline is much much more valuable than that. SPTA shareholders clearly got snookered.

The most attractive product is the diabetic product. I'm not sure if that will transfer to SUPG also. I know SPTA was looking at creating subsidiary to fund and develop the product. SUPG essentially got a gold mine of products.

BEST WISHES
LONE WOLF
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News